As capital sources become more elusive, companies are increasingly exploring creative methods to structure transactions and it is more important than ever to find successful transaction structures that build value. This session will focus on unique financial structures that have been utilized to leverage industry and financing opportunities.
This panel will review the following:
Combined deferred mergers and product development licenses
Debt transactions
Equity lines
The use of business incubators
Moderator:
- Richard A. Kaufman, Partner, Foley & Lardner
Panelists:
- Mark Benedyk, Head of The Pfizer Incubator LLC
- Donna Tempel, Ph.D., President and CEO, Drais Pharmaceuticals
- Jack Lief, Co-Founder, Chairman, President & CEO, Arena Pharmaceuticals
- Michael White, Deal Team Leader, Silicon Valley Bank
Related Insights
March 13, 2026
Innovative Technology Insights
Increased Flexibility for Graphical User Interface Design Patent Applicants
On March 12, 2026, the U.S. Patent and Trademark Office ("USPTO") released new guidance that updates prior USPTO practice guidelines for the examination of design patent applications for computer-generated interfaces, commonly known as graphical user interfaces ("GUIs") and icons. In response to the evolution of computer technology, the USPTO highlighted additional design patent subject matter and eliminated historical drawing requirements to increase flexibility for applicants in the GUI space.
March 13, 2026
Health Care Law Today
Iran-Linked Cyberattack: What U.S. Companies Need to Know Now
Overview On March 11, 2026, independent reports confirmed that one of the largest medical device companies in the United States was the…
March 13, 2026
Innovative Technology Insights
Iran-Linked Cyberattack: What U.S. Companies Need to Know Now
Overview On March 11, 2026, independent reports confirmed that one of the largest medical device companies in the United States was the…